Application Note

Determining Antibody-Drug Conjugate Positional Isomer Distribution With Nonreduced CE-SDS And HIC

By Kyle Luttgeharm, Whitney Pike, Lisa Engelbart, and Sonja Schneider

Step 8- 1290-Bio-LC-DSC02090

Antibody–drug conjugates demand a clear view of both drug-to-antibody ratio (DAR) and where payloads attach, as each shapes efficacy. Hydrophobic interaction chromatography (HIC) excels at resolving DAR distributions, while nonreduced CE-SDS reveals fragmentation patterns linked to conjugation at interchain disulfides. By combining these orthogonal datasets with a system-of-equations approach, it becomes possible to estimate positional isomer abundance without specialized assays. Analysis of a SigmaMAb ADC mimic showed a dominant DAR4 population (41.5%) with drugs at both Fab disulfides, alongside notable DAR2f (19.3%) and DAR6fhh (22.9%) species, and no detectable DAR2h or DAR6ffh. This integrated workflow using Agilent CE-SDS and HIC platforms delivers rapid, actionable insight into ADC structure.

Access the full application note to see how the method can streamline your characterization strategy.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online